Pseudo- @entity56 to XXXX : diagnosis and alternatives.

@entity1 @entity71956 @entity566 @entity619 @entity56 @entity2024 @entity110 @entity288
Two @entity1 treated with parenteral @entity71956 (Triniol) and @entity619 (Sedionbel) are described. A few minutes after administration of the drugs, they presented @entity110 ( @entity1 1 and 2) and @entity2024 ( @entity1 1). The purpose of our study was to determine the cause of the @entity1 ' reactions, the immunological mechanisms involved and whether these @entity1 would be able to tolerate any kind of corticoid. Clinical examinations and skin, oral and parenteral challenges with different @entity288 and ELISA tests were performed. In the two @entity1 , skin and ELISA tests with @entity71956 were negative, as was the prick test with each of its excipients. A single-blind parenteral challenge with Triniol was positive in both @entity1 after the administration of 1 ml of the drug, and negative with its excipients. We also carried out oral and parenteral challenges with other @entity288 and found intolerance to some of them. These results suggest that @entity71956 caused pseudoallergic reactions in our @entity1 . @entity288 different from @entity71956 also produced @entity56 reactions in these @entity1 ; however, a few of them were tolerated. The basic mechanisms of those reactions are not yet fully understood. To our knowledge, this is the first report of a pseudo- @entity566 caused by @entity71956 .
